Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: Hawkmoon who wrote (38196)	8/3/1999 8:09:00 AM
From: long-gone	Respond to of 116753

If the population goes up(people aren't dying from aids) could we see a better gold demand? Friday July 30, 2:58 pm Eastern Time Vical jumps on report of Merck work on AIDS vaccine NEW YORK, July 30 (Reuters) - Vical Inc.'s (Nasdaq:VICL - news) stock surged 35 percent Friday after a newspaper article reported the largest U.S. drug maker, Merck & Co. Inc. (NYSE:MRK - news), was testing an AIDS vaccine that uses the company's technology. Shares of San Diego-based Vical jumped $3.94 to $15 in Nasdaq trading, making it Friday's second biggest percent gainer, with over 3 million shares changing hands. Analysts linked the sharp gain to an article in Friday's Wall Street Journal, which said Merck was planning to begin the first human tests of two promising experimental vaccines for use against AIDS developed as part of a secretive research effort.(cont) biz.yahoo.com